Healios

About:

Healios researches, develops, and manufactures cell and regenerative medicine products for advanced medical treatments.

Website: https://www.healios.co.jp/

Top Investors: iPS Academia Japan, Nikon, Dogan, Nomura, Astem

Description:

Healios aims to commercialize the world’s first pharmaceutical hiPSC derived RPE cell transplantation for treatment of AMD in collaboration with RIKEN, one of the leading research institutes in Japan. The goal of this therapy is to promote the regeneration of retinal function and, consequently, to improve visual function in those affected with retinal degenerative diseases.The significance of the total raised capital fortifies the company’s momentum in the development of therapeutics utilizing the Nobel Prize-winning hiPSC technology and attests its uncompromising commitment to making groundbreaking strides in the field of regenerative medicine.